Bradykinin has been implicated in the pathogenesis of renal inflammation, whereas the role of its receptor 2 (B2RBK; also known as BDKRB2) in FSGS has not been studied. The gene discussed is BDKRB2; the disease is focal segmental glomerulosclerosis.